{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:12:45Z","timestamp":1791886365175,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Arctic Therapeutics LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hereditary cystatin C amyloid angiopathy is a dominantly inherited disease caused by a leucine to glutamine variant of human cystatin C (hCC). L68Q-hCC forms amyloid deposits in brain arteries associated with micro-infarcts, leading ultimately to paralysis, dementia and death in young adults. To evaluate the ability of molecules to interfere with aggregation of hCC while informing about cellular toxicity, we generated cells that produce and secrete WT and L68Q-hCC and have detected high-molecular weight complexes formed from the mutant protein. Incubations of either lysate or supernatant containing L68Q-hCC with reducing agents glutathione or N-acetyl-cysteine (NAC) breaks oligomers into monomers. Six L68Q-hCC carriers taking NAC had skin biopsies obtained to determine if hCC deposits were reduced following NAC treatment. Remarkably, ~50\u201390% reduction of L68Q-hCC staining was observed in five of the treated carriers suggesting that L68Q-hCC is a clinical target for reducing agents.<\/jats:p>","DOI":"10.1038\/s41467-021-22120-4","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T11:04:44Z","timestamp":1616497484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-6862","authenticated-orcid":false,"given":"Michael E.","family":"March","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Gutierrez-Uzquiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbjorg Osk","family":"Snorradottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia S.","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia Fonseca","family":"Balvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorgeir","family":"Gestsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M. A.","family":"Sleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlly","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi J.","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birkir Thor","family":"Bragason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Olafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astridur","family":"Palsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-7461","authenticated-orcid":false,"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"22120_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(88)90641-1","volume":"2","author":"A Palsdottir","year":"1988","unstructured":"Palsdottir, A. et al. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2, 603\u2013604 (1988).","journal-title":"Lancet"},{"key":"22120_CR2","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1016\/S0021-9258(18)67380-6","volume":"261","author":"M Abrahamson","year":"1986","unstructured":"Abrahamson, M., Barrett, A. J., Salvesen, G. & Grubb, A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 261, 11282\u201311289 (1986).","journal-title":"J. Biol. Chem."},{"key":"22120_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2013.08.029","volume":"1535","author":"AO Snorradottir","year":"2013","unstructured":"Snorradottir, A. O. et al. Deposition of collagen IV and aggrecan in leptomeningeal arteries of hereditary brain haemorrhage with amyloidosis. Brain Res. 1535, 106\u2013114 (2013).","journal-title":"Brain Res."},{"key":"22120_CR4","doi-asserted-by":"publisher","first-page":"e1000099","DOI":"10.1371\/journal.pgen.1000099","volume":"4","author":"A Palsdottir","year":"2008","unstructured":"Palsdottir, A. et al. A drastic reduction in the life span of cystatin C L68Q carriers due to life-style changes during the last two centuries. PLoS Genet. 4, e1000099 (2008).","journal-title":"PLoS Genet."},{"key":"22120_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/brain\/95.2.387","volume":"95","author":"G Gudmundsson","year":"1972","unstructured":"Gudmundsson, G., Hallgrimsson, J., Jonasson, T. A. & Bjarnason, O. Hereditary cerebral haemorrhage with amyloidosis. Brain 95, 387\u2013404 (1972).","journal-title":"Brain"},{"key":"22120_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2015.06.019","volume":"1622","author":"A Osk Snorradottir","year":"2015","unstructured":"Osk Snorradottir, A. et al. Parenchymal cystatin C focal deposits and glial scar formation around brain arteries in Hereditary Cystatin C Amyloid Angiopathy. Brain Res. 1622, 149\u2013162 (2015).","journal-title":"Brain Res."},{"key":"22120_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-5793(87)80695-6","volume":"216","author":"M Abrahamson","year":"1987","unstructured":"Abrahamson, M., Grubb, A., Olafsson, I. & Lundwall, A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 216, 229\u2013233 (1987).","journal-title":"FEBS Lett."},{"key":"22120_CR8","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1073\/pnas.79.9.3024","volume":"79","author":"A Grubb","year":"1982","unstructured":"Grubb, A. & Lofberg, H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc. Natl Acad. Sci. USA 79, 3024\u20133027 (1982).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22120_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0065-2423(01)35015-1","volume":"35","author":"AO Grubb","year":"2000","unstructured":"Grubb, A. O. Cystatin C\u2014properties and use as diagnostic marker. Adv. Clin. Chem. 35, 63\u201399 (2000).","journal-title":"Adv. Clin. Chem."},{"key":"22120_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1902\/jop.1996.67.3.205","volume":"67","author":"YM Henskens","year":"1996","unstructured":"Henskens, Y. M. et al. Effect of periodontal treatment on the protein composition of whole and parotid saliva. J. Periodontol. 67, 205\u2013212 (1996).","journal-title":"J. Periodontol."},{"key":"22120_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0014-5793(91)80804-C","volume":"285","author":"V Turk","year":"1991","unstructured":"Turk, V. & Bode, W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213\u2013219 (1991).","journal-title":"FEBS Lett."},{"key":"22120_CR12","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1002\/j.1460-2075.1988.tb03109.x","volume":"7","author":"W Bode","year":"1988","unstructured":"Bode, W. et al. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7, 2593\u20132599 (1988).","journal-title":"EMBO J."},{"key":"22120_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jsb.2010.11.009","volume":"173","author":"M Orlikowska","year":"2011","unstructured":"Orlikowska, M., Jankowska, E., Kolodziejczyk, R., Jaskolski, M. & Szymanska, A. Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C. J. Struct. Biol. 173, 406\u2013413 (2011).","journal-title":"J. Struct. Biol."},{"key":"22120_CR14","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1742-4658.2010.07596.x","volume":"277","author":"R Kolodziejczyk","year":"2010","unstructured":"Kolodziejczyk, R. et al. Crystal structure of human cystatin C stabilized against amyloid formation. FEBS J. 277, 1726\u20131737 (2010).","journal-title":"FEBS J."},{"key":"22120_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/86188","volume":"8","author":"R Janowski","year":"2001","unstructured":"Janowski, R. et al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8, 316\u2013320 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"22120_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jmb.2004.06.013","volume":"341","author":"R Janowski","year":"2004","unstructured":"Janowski, R., Abrahamson, M., Grubb, A. & Jaskolski, M. Domain swapping in N-truncated human cystatin C. J. Mol. Biol. 341, 151\u2013160 (2004).","journal-title":"J. Mol. Biol."},{"key":"22120_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/prot.20633","volume":"61","author":"R Janowski","year":"2005","unstructured":"Janowski, R., Kozak, M., Abrahamson, M., Grubb, A. & Jaskolski, M. 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets. Proteins 61, 570\u2013578 (2005).","journal-title":"Proteins"},{"key":"22120_CR18","doi-asserted-by":"publisher","first-page":"18318","DOI":"10.1074\/jbc.M611368200","volume":"282","author":"M Wahlbom","year":"2007","unstructured":"Wahlbom, M. et al. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J. Biol. Chem. 282, 18318\u201318326 (2007).","journal-title":"J. Biol. Chem."},{"key":"22120_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jsb.2015.07.013","volume":"191","author":"PL Tsiolaki","year":"2015","unstructured":"Tsiolaki, P. L., Louros, N. N., Hamodrakas, S. J. & Iconomidou, V. A. Exploring the \u2018aggregation-prone\u2019 core of human Cystatin C: a structural study. J. Struct. Biol. 191, 272\u2013280 (2015).","journal-title":"J. Struct. Biol."},{"key":"22120_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/13506129.2012.734345","volume":"19","author":"JD Sipe","year":"2012","unstructured":"Sipe, J. D. et al. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 19, 167\u2013170 (2012).","journal-title":"Amyloid"},{"key":"22120_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1750-3639.2006.tb00561.x","volume":"16","author":"A Palsdottir","year":"2006","unstructured":"Palsdottir, A., Snorradottir, A. O. & Thorsteinsson, L. Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. Brain Pathol. 16, 55\u201359 (2006).","journal-title":"Brain Pathol."},{"key":"22120_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/labinvest.2016.133","volume":"97","author":"AO Snorradottir","year":"2017","unstructured":"Snorradottir, A. O. et al. Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy. Lab. Investig. 97, 383\u2013394 (2017).","journal-title":"Lab. Investig."},{"key":"22120_CR23","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.1074\/jbc.M117.786558","volume":"292","author":"TJ Perlenfein","year":"2017","unstructured":"Perlenfein, T. J., Mehlhoff, J. D. & Murphy, R. M. Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with beta-amyloid. J. Biol. Chem. 292, 11485\u201311498 (2017).","journal-title":"J. Biol. Chem."},{"key":"22120_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3109\/00365513.2011.621026","volume":"71","author":"G \u00d6stner","year":"2011","unstructured":"\u00d6stner, G. et al. High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy. Scand. J. Clin. Lab. Investig. 71, 676\u2013682 (2011).","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"22120_CR25","doi-asserted-by":"publisher","first-page":"17015","DOI":"10.1021\/ja107552s","volume":"132","author":"J Chen","year":"2010","unstructured":"Chen, J., Armstrong, A. H., Koehler, A. N. & Hecht, M. H. Small molecule microarrays enable the discovery of compounds that bind the Alzheimer\u2019s Abeta peptide and reduce its cytotoxicity. J. Am. Chem. Soc. 132, 17015\u201317022 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"22120_CR26","doi-asserted-by":"publisher","first-page":"24236","DOI":"10.1074\/jbc.M402621200","volume":"279","author":"M Nilsson","year":"2004","unstructured":"Nilsson, M. et al. Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J. Biol. Chem. 279 24236\u201324245 (2004).","journal-title":"J. Biol. Chem."},{"key":"22120_CR27","doi-asserted-by":"publisher","first-page":"16438","DOI":"10.1074\/jbc.M113.469593","volume":"288","author":"G \u00d6stner","year":"2013","unstructured":"\u00d6stner, G. et al. Stabilization, characterization, and selective removal of cystatin C amyloid oligomers. J. Biol. Chem. 288, 16438\u201316450 (2013).","journal-title":"J. Biol. Chem."},{"key":"22120_CR28","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bcp.2012.09.010","volume":"84","author":"D Giustarini","year":"2012","unstructured":"Giustarini, D., Milzani, A., Dalle-Donne, I., Tsikas, D. & Rossi, R. N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential. Biochem. Pharm. 84, 1522\u20131533 (2012).","journal-title":"Biochem. Pharm."},{"key":"22120_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2004.09.025","volume":"38","author":"L Grinberg","year":"2005","unstructured":"Grinberg, L., Fibach, E., Amer, J. & Atlas, D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic. Biol. Med. 38, 136\u2013145 (2005).","journal-title":"Free Radic. Biol. Med."},{"key":"22120_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF01605784","volume":"417","author":"E Benedikz","year":"1990","unstructured":"Benedikz, E., Blondal, H. & Gudmundsson, G. Skin deposits in hereditary cystatin C amyloidosis. Virchows Arch. A Pathol. Anat. Histopathol. 417, 325\u2013331 (1990).","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"22120_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/(SICI)1097-4652(199712)173:3<423::AID-JCP15>3.0.CO;2-C","volume":"173","author":"GS Merz","year":"1997","unstructured":"Merz, G. S. et al. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J. Cell Physiol. 173, 423\u2013432 (1997).","journal-title":"J. Cell Physiol."},{"key":"22120_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","volume":"84","author":"SA Farr","year":"2003","unstructured":"Farr, S. A. et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem 84, 1173\u20131183 (2003).","journal-title":"J. Neurochem"},{"key":"22120_CR33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.parkreldis.2015.02.020","volume":"21","author":"M Katz","year":"2015","unstructured":"Katz, M. et al. Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 21, 500\u2013503 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"22120_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/emm.2007.82","volume":"39","author":"KS Lee","year":"2007","unstructured":"Lee, K. S. et al. A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp. Mol. Med. 39, 756\u2013768 (2007).","journal-title":"Exp. Mol. Med."},{"key":"22120_CR35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1471-4159.2004.02428.x","volume":"89","author":"D Offen","year":"2004","unstructured":"Offen, D. et al. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J. Neurochem. 89, 1241\u20131251 (2004).","journal-title":"J. Neurochem."},{"key":"22120_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt, K. E. & Tabas, I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 14, 575\u2013585 (2011).","journal-title":"Cell Metab."},{"issue":"Suppl 2","key":"22120_CR37","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.2337\/dc09-S333","volume":"32","author":"JA Davidson","year":"2009","unstructured":"Davidson, J. A. & Parkin, C. G. Is hyperglycemia a causal factor in cardiovascular disease? Does proving this relationship really matter? Yes. Diabetes Care 32(Suppl 2), S331\u2013S333 (2009).","journal-title":"Diabetes Care"},{"key":"22120_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-2008-1040481","volume":"10","author":"LD DeLeve","year":"1990","unstructured":"DeLeve, L. D. & Kaplowitz, N. Importance and regulation of hepatic glutathione. Semin. Liver Dis. 10, 251\u2013266 (1990).","journal-title":"Semin. Liver Dis."},{"key":"22120_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0304-4165(78)90037-5","volume":"539","author":"R Hahn","year":"1978","unstructured":"Hahn, R., Wendel, A. & Flohe, L. The fate of extracellular glutathione in the rat. Biochim. Biophys. Acta 539, 324\u2013337 (1978).","journal-title":"Biochim. Biophys. Acta"},{"key":"22120_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-4165(77)90084-8","volume":"498","author":"JT Isaacs","year":"1977","unstructured":"Isaacs, J. T. & Binkley, F. Cyclic AMP-dependent control of the rat hepatic glutathione disulfide-sulfhydryl ratio. Biochim. Biophys. Acta 498, 29\u201338 (1977).","journal-title":"Biochim. Biophys. Acta"},{"key":"22120_CR41","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.freeradbiomed.2007.11.008","volume":"44","author":"M Kemp","year":"2008","unstructured":"Kemp, M., Go, Y. M. & Jones, D. P. Nonequilibrium thermodynamics of thiol\/disulfide redox systems: a perspective on redox systems biology. Free Radic. Biol. Med 44, 921\u2013937 (2008).","journal-title":"Free Radic. Biol. Med"},{"key":"22120_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1172\/JCI111182","volume":"73","author":"BH Lauterburg","year":"1984","unstructured":"Lauterburg, B. H., Smith, C. V., Hughes, H. & Mitchell, J. R. Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J. Clin. Investig. 73, 124\u2013133 (1984).","journal-title":"J. Clin. Investig."},{"key":"22120_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev.bi.45.070176.003015","volume":"45","author":"A Meister","year":"1976","unstructured":"Meister, A. & Tate, S. S. Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. Annu. Rev. Biochem. 45, 559\u2013604 (1976).","journal-title":"Annu. Rev. Biochem."},{"key":"22120_CR44","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","volume":"52","author":"A Meister","year":"1983","unstructured":"Meister, A. & Anderson, M. E. Glutathione. Annu. Rev. Biochem. 52, 711\u2013760 (1983).","journal-title":"Annu. Rev. Biochem."},{"key":"22120_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0024-3205(92)90509-N","volume":"51","author":"S Uhlig","year":"1992","unstructured":"Uhlig, S. & Wendel, A. The physiological consequences of glutathione variations. Life Sci. 51, 1083\u20131094 (1992).","journal-title":"Life Sci."},{"key":"22120_CR46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"KR Atkuri","year":"2007","unstructured":"Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A. & Herzenberg, L. A. N-Acetylcysteine\u2014a safe antidote for cysteine\/glutathione deficiency. Curr. Opin. Pharm. 7, 355\u2013359 (2007).","journal-title":"Curr. Opin. Pharm."},{"key":"22120_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2125.2005.02523.x","volume":"61","author":"ML Aitio","year":"2006","unstructured":"Aitio, M. L. N-acetylcysteine\u2014passe-partout or much ado about nothing? Br. J. Clin. Pharm. 61, 5\u201315 (2006).","journal-title":"Br. J. Clin. Pharm."},{"key":"22120_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/brb3.208","volume":"4","author":"R Bavarsad Shahripour","year":"2014","unstructured":"Bavarsad Shahripour, R., Harrigan, M. R. & Alexandrov, A. V. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav. 4, 108\u2013122 (2014).","journal-title":"Brain Behav."},{"key":"22120_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0735-1097(00)01093-7","volume":"37","author":"NP Andrews","year":"2001","unstructured":"Andrews, N. P., Prasad, A. & Quyyumi, A. A. N-acetylcysteine improves coronary and peripheral vascular function. J. Am. Coll. Cardiol. 37, 117\u2013123 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"22120_CR50","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","volume":"57","author":"JC Adair","year":"2001","unstructured":"Adair, J. C., Knoefel, J. E. & Morgan, N. Controlled trial of N-acetylcysteine for patients with probable Alzheimer\u2019s disease. Neurology 57, 1515\u20131517 (2001).","journal-title":"Neurology"},{"key":"22120_CR51","first-page":"201","volume":"4","author":"Y Hara","year":"2017","unstructured":"Hara, Y., McKeehan, N., Dacks, P. A. & Fillit, H. M. Evaluation of the neuroprotective potential of N-acetylcysteine for prevention and treatment of cognitive aging and dementia. J. Prev. Alzheimers Dis. 4, 201\u2013206 (2017).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"22120_CR52","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1074-7613(00)80065-5","volume":"10","author":"GB Cohen","year":"1999","unstructured":"Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661\u2013671 (1999).","journal-title":"Immunity"},{"key":"22120_CR53","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"22120_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/978-1-4939-3756-1_21","volume":"1449","author":"S Tenreiro","year":"2016","unstructured":"Tenreiro, S., Macedo, D., Marijanovic, Z. & Outeiro, T. F. Analysis of protein oligomeric species by sucrose gradients. Methods Mol. Biol. 1449, 331\u2013339 (2016).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22120-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:33:16Z","timestamp":1669980796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22120-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22120"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22120-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"19 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests. Drs Hakonarson and Kao are co-founders of Arctic Therapeutics LLC, which is funding the study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1827"}}